471 related articles for article (PubMed ID: 25884795)
1. Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study.
Shigekawa T; Osaki A; Sekine H; Sato N; Kanbayashi C; Sano H; Takeuchi H; Ueda S; Nakamiya N; Sugitani I; Sugiyama M; Shimada H; Hirokawa E; Takahashi T; Saeki T
BMC Cancer; 2015 Apr; 15():253. PubMed ID: 25884795
[TBL] [Abstract][Full Text] [Related]
2. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
[TBL] [Abstract][Full Text] [Related]
3. A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates.
Tsuchiya T; Nagayasu T; Yamasaki N; Matsumoto K; Miyazaki T; Tagawa T; Nakamura A; Minami H; Taniguchi H; Akamine S; Hisano H; Taniguchi Y
Clin Lung Cancer; 2012 Nov; 13(6):464-9. PubMed ID: 22424872
[TBL] [Abstract][Full Text] [Related]
4. A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
Oki E; Murata A; Yoshida K; Maeda K; Ikejiri K; Munemoto Y; Sasaki K; Matsuda C; Kotake M; Suenaga T; Matsuda H; Emi Y; Kakeji Y; Baba H; Hamada C; Saji S; Maehara Y
Ann Oncol; 2016 Jul; 27(7):1266-72. PubMed ID: 27056996
[TBL] [Abstract][Full Text] [Related]
5. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697
[TBL] [Abstract][Full Text] [Related]
6. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
Sakuramoto S; Sasako M; Yamaguchi T; Kinoshita T; Fujii M; Nashimoto A; Furukawa H; Nakajima T; Ohashi Y; Imamura H; Higashino M; Yamamura Y; Kurita A; Arai K;
N Engl J Med; 2007 Nov; 357(18):1810-20. PubMed ID: 17978289
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of a 2-week S-1 administration followed by 1-week rest for advanced and metastatic breast cancer].
Fujii K; Kosaka J; Mouri Y; Yoshida M; Yorozuya K; Nakano S; Akizuki M; Fukutomi T; Kobayashi K
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1467-70. PubMed ID: 21918343
[TBL] [Abstract][Full Text] [Related]
9. Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer.
Jeong JH; Ryu MH; Ryoo BY; Lee SS; Park I; Lee SH; Kim KC; Yook JH; Oh ST; Kim BS; Kang YK
Cancer Chemother Pharmacol; 2012 Oct; 70(4):523-9. PubMed ID: 22864947
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.
Rino Y; Takanashi Y; Yukawa N; Saeki H; Wada H; Kanari M; Yamada R; Satoh T; Yamamoto N; Imada T
Anticancer Res; 2006; 26(2B):1455-62. PubMed ID: 16619558
[TBL] [Abstract][Full Text] [Related]
11. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil and oteracil potassium) for colorectal cancer.
Kawahara H; Watanabe K; Ushigome T; Noaki R; Kobayashi S; Yanaga K
Hepatogastroenterology; 2012; 59(113):134-7. PubMed ID: 22251528
[TBL] [Abstract][Full Text] [Related]
12. [An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)].
Taguchi T; Morimoto K; Horikoshi N; Takashima S; Toge T; Kimura M; Sano M; Aoyama H; Ota J; Noguchi S
Gan To Kagaku Ryoho; 1998 Jun; 25(7):1035-43. PubMed ID: 9644319
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer.
Jiang H; Qian J; Zhao P; Zhang X; Zheng Y; Mao C; Zheng Y; Chen L; Wang Y; Mou H; Fang W; Teng L; Xu N
Cancer Chemother Pharmacol; 2015 Jul; 76(1):197-203. PubMed ID: 26013324
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer.
Takashima T; Nakayama T; Yoshidome K; Kawajiri H; Kamigaki S; Tsurutani J; Arai T; Ito T; Komoike Y; Doi T; Masuda N; Miyauchi K; Miyoshi Y; Sakamoto J; Morita S; Taguchi T
Anticancer Res; 2014 Jul; 34(7):3583-8. PubMed ID: 24982373
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and toxicity of adjuvant chemotherapy using S-1 granules for local advanced squamous cell carcinoma of the head and neck.
Suzuki S; Honda K; Sato T; Yamazaki K; Ishikawa K
J Chemother; 2015 Oct; 27(5):297-300. PubMed ID: 25971448
[TBL] [Abstract][Full Text] [Related]
16. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.
Inoue T; Yachida S; Usuki H; Kimura T; Hagiike M; Okano K; Suzuki Y
Ann Surg Oncol; 2012 Sep; 19(9):2937-45. PubMed ID: 22466666
[TBL] [Abstract][Full Text] [Related]
17. [Problems of adjuvant chemotherapy with S-1 for gastric cancer].
Teshima S; Saito T; Endo A; Yunome G; Harada A; Ooshio H; Kodama H; Takeda K; Kikuchi S
Gan To Kagaku Ryoho; 2010 Feb; 37(2):255-8. PubMed ID: 20154480
[TBL] [Abstract][Full Text] [Related]
18. Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancer.
Naito T; Seto T; Takeda K; Goto K; Okamoto I; Nakagawa K; Ohba T; Murakami H; Takahashi T; Yamanaka T; Yamamoto N
Lung Cancer; 2014 Dec; 86(3):339-43. PubMed ID: 25453619
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working Group.
Saek T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Aoyama H; Ota J; Noguchi S; Taguchi T
Breast Cancer; 2004; 11(2):194-202. PubMed ID: 15550867
[TBL] [Abstract][Full Text] [Related]
20. [Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan].
Yagi M; Watanabe S; Yoshino S; Hazama S; Suga T; Nakazawa S
Gan To Kagaku Ryoho; 2010 Mar; 37(3):457-62. PubMed ID: 20332683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]